MediciNova

MNOV

Market cap $78.6M

1.60 USD

+0.12

8.11%

At close Updated Feb 17, 4:00 PM EST

Pre-market

After hours

1.65

+0.05

3.12%

1 day

8.11%

5 days

-11.11%

1 month

-4.76%

3 months

13.48%

6 months

22.14%

Year to date

20.3%

1 year

-16.67%

5 years

-73.47%

10 years

-64.21%

About: MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Employees: 6

Healthcare Biotechnology